Gangrene cost-effectiveness of therapy

Jump to navigation Jump to search

Gangrene Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Gangrene from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gangrene cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gangrene cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gangrene cost-effectiveness of therapy

CDC on Gangrene cost-effectiveness of therapy

Gangrene cost-effectiveness of therapy in the news

Blogs on Gangrene cost-effectiveness of therapy

Directions to Hospitals Treating Gangrene

Risk calculators and risk factors for Gangrene cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.


Overview

Gangrene is a potential life-threatening condition if not given prompt treatment. Although the incidence is just low, gangrene can generate a high healthcare cost.

Cost-Effectiveness of Therapy

References

  1. Jiménez-Pacheco A, Arrabal-Polo MÁ, Arias-Santiago S, Arrabal-Martín M, Nogueras-Ocaña M, Zuluaga-Gómez A (2012). "Fournier gangrene: description of 37 cases and analysis of associated health care costs". Actas Dermosifiliogr. 103 (1): 29–35. doi:10.1016/j.adengl.2011.04.007. PMID 22445562.

Template:WH

Template:WS